Literature DB >> 27520671

Phosphorylation of phospholamban in ischemia-reperfusion injury: Functional role of Thr(17) residue.

A Mattiazzi1, C Mundiña-Weilenmann1, L Vittone1, M Said1.   

Abstract

Phospholamban (PLB) is a sarcoplasmic reticulum (SR) protein that when phosphorylated at Ser(16) by PKA and/or at Thr(17) by CaMKII increases the affinity of the SR Ca(2+) pump for Ca(2+). PLB is therefore, a critical regulator of SR function, myocardial relaxation and myocardial contractility. The present study was undertaken to examine the status of PLB phosphorylation after ischemia and reperfusion and to provide evidence about the possible role of the phosphorylation of Thr(17) PLB residue on the recovery of contractility and relaxation after a period of ischemia. Experiments were performed in Langendorff perfused hearts from Wistar rats. Hearts were submitted to a protocol of global normothermic ischemia and reperfusion. The results showed that (1) the phosphorylation of Ser(16) and Thr(17) residues of PLB increased at the end of the ischemia and the onset of reperfusion, respectively. The increase in Thr(17) phosphorylation was associated with a recovery of relaxation to preischemic values. This recovery occurred in spite of the fact that contractility was depressed. (2) The reperfusion-induced increase in Thr(17) phosphorylation was dependent on Ca(2+) entry to the cardiac cell. This Ca(2+) influx would mainly occur by the coupled activation of the Na(+)/H(+) exchanger and the Na(+)/Ca(2+) exchanger working in the reverse mode, since phosphorylation of Thr(17) was decreased by inhibition of these exchangers and not affected by blockade of the L-type Ca(2+) channels. (3) Specific inhibition of CaMKII by KN93 significantly decreased Thr(17) phosphorylation. This decrease was associated with an impairment of myocardial relaxation. The present study suggests that the phosphorylation of Thr(17) of PLB upon reflow, may favor the full recovery of relaxation after ischemia. (Mol Cell Biochem 263: 131-136, 2004).

Entities:  

Keywords:  ischemia-reperfusion; isolated perfused heart; phospholamban phosphorylation

Year:  2004        PMID: 27520671     DOI: 10.1023/B:MCBI.0000041854.72511.14

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

1.  Biochemical mechanism(s) of stunning in conscious dogs.

Authors:  H Lüss; A Meissner; N Rolf; H Van Aken; P Bokník; U Kirchhefer; J Knapp; S Läer; B Linck; I Lüss; F U Müller; J Neumann; W Schmitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-07       Impact factor: 4.733

2.  Time course and mechanisms of phosphorylation of phospholamban residues in ischemia-reperfused rat hearts. Dissociation of phospholamban phosphorylation pathways.

Authors:  Leticia Vittone; Cecilia Mundiña-Weilenmann; Matilde Said; Paola Ferrero; Alicia Mattiazzi
Journal:  J Mol Cell Cardiol       Date:  2002-01       Impact factor: 5.000

3.  Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity.

Authors:  D R Witcher; R J Kovacs; H Schulman; D C Cefali; L R Jones
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

4.  Role of troponin I proteolysis in the pathogenesis of stunned myocardium.

Authors:  W D Gao; D Atar; Y Liu; N G Perez; A M Murphy; E Marban
Journal:  Circ Res       Date:  1997-03       Impact factor: 17.367

5.  Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum.

Authors:  P James; M Inui; M Tada; M Chiesi; E Carafoli
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

6.  Transgenic approaches to define the functional role of dual site phospholamban phosphorylation.

Authors:  W Luo; G Chu; Y Sato; Z Zhou; V J Kadambi; E G Kranias
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

7.  Mechanisms involved in the acidosis enhancement of the isoproterenol-induced phosphorylation of phospholamban in the intact heart.

Authors:  L Vittone; C Mundiña-Weilenmann; M Said; A Mattiazzi
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

8.  Phosphorylation of phospholamban at threonine-17 in the absence and presence of beta-adrenergic stimulation in neonatal rat cardiomyocytes.

Authors:  S Bartel; D Vetter; W P Schlegel; G Wallukat; E G Krause; P Karczewski
Journal:  J Mol Cell Cardiol       Date:  2000-12       Impact factor: 5.000

9.  A novel mechanism for myocardial stunning involving impaired Ca(2+) handling.

Authors:  S J Kim; R K Kudej; A Yatani; Y K Kim; G Takagi; R Honda; D A Colantonio; J E Van Eyk; D E Vatner; R L Rasmusson; S F Vatner
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

10.  Phosphorylation of phospholamban in intact myocardium. Role of Ca2+-calmodulin-dependent mechanisms.

Authors:  J P Lindemann; A M Watanabe
Journal:  J Biol Chem       Date:  1985-04-10       Impact factor: 5.157

View more
  1 in total

1.  Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity.

Authors:  Shubha Murthy; Olha M Koval; Juan M Ramiro Diaz; Santosh Kumar; Daniel Nuno; Jason A Scott; Chantal Allamargot; Linda J Zhu; Kim Broadhurst; Velarchana Santhana; William J Kutschke; Kaikobad Irani; Kathryn G Lamping; Isabella M Grumbach
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.